10 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
plant. The proteasome degrades poly-ubiquitinated proteins into their component amino acids, and these amino acids can then be recycled to form new
ARS
2023 FY
CCCC
C4 Therapeutics Inc
28 Apr 23
Annual report to shareholders
7:03am
amino acids, and these amino acids can then be recycled to form new proteins or can be excreted by the cell. This process is illustrated
10-K
2020 FY
CCCC
C4 Therapeutics Inc
11 Mar 21
Annual report
4:19pm
can then be recycled to form new proteins or can be excreted by the cell. This process is illustrated in the following graphic.
Approximately five
8-K
EX-99.1
r0m6b
19 Nov 20
Regulation FD Disclosure
5:00pm
424B4
lbjr34o18dy0b7f9
2 Oct 20
Prospectus supplement with pricing info
5:10pm
S-1/A
hkofmb
28 Sep 20
IPO registration (amended)
6:07am
S-1
905vyis2gjwk73s
10 Sep 20
IPO registration
5:26pm
DRS
8jvfd3nvuhab4uml8e6
6 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next